Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MEHTA, Jayesh")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 30

  • Page / 2
Export

Selection :

  • and

Novel therapies in multiple myelomaSINGHAL, Seema; MEHTA, Jayesh.International journal of hematology. 2003, Vol 77, Num 3, pp 226-231, issn 0925-5710, 6 p.Article

Acyclovir to Prevent Reactivation of Varicella Zoster Virus (Herpes Zoster) in Multiple Myeloma Patients Receiving Bortezomib TherapyVICKREY, Eric; ALLEN, Sharon; MEHTA, Jayesh et al.Cancer. 2009, Vol 115, Num 1, pp 229-232, issn 0008-543X, 4 p.Article

Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infectionTEWARY, Poonam; MEHTA, Jayesh; SUKUMARAN, Bindu et al.FEMS immunology and medical microbiology. 2004, Vol 42, Num 2, pp 241-248, issn 0928-8244, 8 p.Article

Recent developments and future directions in the treatment of multiple MyelomaPICHARDO, Diely; SINGHAL, Seema; MEHTA, Jayesh et al.Cancer biotherapy & radiopharmaceuticals. 2003, Vol 18, Num 4, pp 497-511, issn 1084-9785, 15 p.Article

Hyperviscosity syndrome in plasma cell dyscrasiasMEHTA, Jayesh; SINGHAL, Seema.Seminars in thrombosis and hemostasis. 2003, Vol 29, Num 5, pp 467-471, issn 0094-6176, 5 p.Article

How I treat elderly patients with myelomaMEHTA, Jayesh; CAVO, Michele; SINGHAL, Seema et al.Blood. 2010, Vol 116, Num 13, pp 2215-2223, issn 0006-4971, 9 p.Article

Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001)SAFDAR, Amar; SINGHAL, Seema; MEHTA, Jayesh et al.Cancer. 2004, Vol 100, Num 11, pp 2456-2461, issn 0008-543X, 6 p.Article

Variability of cyclosporine concentrations by HPLC and TDX monoclonal assay methods, application of a correction factor, and description of a novel clinical approach to determine the practical consequences of changing assay techniqueTRIFILIO, Steven M; SCHEETZ, Marc; BORENSZTAJN, Jayme et al.Clinical transplantation. 2013, Vol 27, Num 1, pp 154-161, issn 0902-0063, 8 p.Article

Long-term outcome results of the first tandem autotransplant trial for multiple myelomaBARLOGIE, Bart; TRICOT, Guido J; HOERING, Antje et al.British journal of haematology. 2006, Vol 135, Num 2, pp 158-164, issn 0007-1048, 7 p.Article

Regression of Cardiac Amyloid After Autologous Stem-cell TransplantationBLAIR, John E. A; ZEIGLER, Sanford M; MEHTA, Jayesh et al.The Journal of heart and lung transplantation. 2009, Vol 28, Num 7, pp 746-748, issn 1053-2498, 3 p.Article

Brain repair by hematopoietic growth factors in a rat model of strokeZHAO, Li-Ru; SINGHAL, Seema; DUAN, Wei-Ming et al.Stroke (1970). 2007, Vol 38, Num 9, pp 2584-2591, issn 0039-2499, 8 p.Article

The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemiaPOWLES, Ray; SIROHI, Bhawna; TRELEAVEN, Jennifer et al.Blood. 2002, Vol 100, Num 5, pp 1641-1647, issn 0006-4971, 7 p.Article

First thalidomide clinical trial in multiple myeloma : a decade laterVAN RHEE, Frits; DHODAPKAR, Madhav; CROWLEY, John et al.Blood. 2008, Vol 112, Num 4, pp 1035-1038, issn 0006-4971, 4 p.Article

Practice guidelines for lipid-based amphotericin B in stem cell transplant recipientsQUILITZ, Rod E; ARNOLD, Alana D; BRIONES, Gabriel R et al.The Annals of pharmacotherapy. 2001, Vol 35, Num 2, pp 206-216, issn 1060-0280Article

Yttrium-90 Ibritumomab Tiuxetan Doses Calculated to Deliver up to 15 Gy to Critical Organs May Be Safely Combined With High-Dose BEAM and Autologous Transplantation in Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaWINTER, Jane N; INWARDS, David J; MICALLEF, Ivana et al.Journal of clinical oncology. 2009, Vol 27, Num 10, pp 1653-1659, issn 0732-183X, 7 p.Article

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients : a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. CommentaryMEHTA, Jayesh; WINSTON, Drew J; CHAO, Nelson et al.Blood. 2008, Vol 111, Num 11, issn 0006-4971, 5265-5266, 5403-5410 [10 p.]Article

Serial Plasma Voriconazole Concentrations after Allogeneic Hematopoietic Stem Cell TransplantationTRIFILIO, Steven M; YARNOLD, Paul R; SCHEETZ, Marc H et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 1793-1796, issn 0066-4804, 4 p.Article

Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipientsTRIFILIO, Steve; PENNICK, Gennethel; GORDON, Leo et al.Cancer. 2007, Vol 109, Num 8, pp 1532-1535, issn 0008-543X, 4 p.Article

F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphomaGENTZLER, Ryan D; EVENS, Andrew M; SINGHAL, Seema et al.British journal of haematology. 2014, Vol 165, Num 6, pp 793-800, issn 0007-1048, 8 p.Article

Instability of Immunophenotype in Plasma Cell MyelomaWENQING CAO; GOOLSBY, Charles L; NELSON, Beverly P et al.American journal of clinical pathology. 2008, Vol 129, Num 6, pp 926-933, issn 0002-9173, 8 p.Article

Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in ratsZHAO, Li-Ru; BERRA, Hector H; DUAN, Wei-Ming et al.Stroke (1970). 2007, Vol 38, Num 10, pp 2804-2811, issn 0039-2499, 8 p.Article

Hematopoietic growth factors pass through the blood-brain barrier in intact ratsZHAO, Li-Ru; NAVALITLOHA, Yot; SINGHAL, Seema et al.Experimental neurology (Print). 2007, Vol 204, Num 2, pp 569-573, issn 0014-4886, 5 p.Article

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remissionTALLMAN, Martin S; DEWALD, Gordon W; ROWE, Jacob M et al.Blood. 2007, Vol 110, Num 1, pp 409-417, issn 0006-4971, 9 p.Article

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation. CommentaryMEHTA, Jayesh; SANCHORAWALA, Vaishali; SKINNER, Martha et al.Blood. 2007, Vol 110, Num 10, issn 0006-4971, 3490-3491, 3561-3563 [5 p.]Article

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3DIMOPOULOS, Meletios; KYLE, Robert; AVET-LOISEAU, Hervé et al.Blood. 2011, Vol 117, Num 18, pp 4701-4705, issn 0006-4971, 5 p.Article

  • Page / 2